The airways pharmacology of DNK333, a po
β
C.A. Lewis; A.Z. El-Hashim; M. Gerspacher; K. Hoshiko; L. Mazzoni; H.-J. Pfannku
π
Article
π
2004
π
John Wiley and Sons
π
English
β 309 KB
## Abstract The airways' pharmacology of DNK333 ((1R,3R,2E)βNβ[3,4βdichlorobenzyl)]β4β[(hexahydroβ2βoxoβ1Hβazepinβ3βyl)amino]βNβmethylβ3,5bis(trifluoromethyl) benzamide), a potent and selective dual NK~1~/NK~2~ neurokinin receptor antagonist is described in the present paper. DNK333 bound with high